Invenomic Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$47.1M | |
| 2 | +$40.9M | |
| 3 | +$39.4M | |
| 4 |
Intuit
INTU
|
+$37.1M |
| 5 |
SPS Commerce
SPSC
|
+$33.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$73.2M | |
| 2 | +$52.2M | |
| 3 | +$46.6M | |
| 4 |
RingCentral
RNG
|
+$30.2M |
| 5 |
Haemonetics
HAE
|
+$28.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.19% |
| 2 | Healthcare | 19.57% |
| 3 | Industrials | 14.44% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Communication Services | 7.96% |
Similar funds
Invenomic Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Invenomic Capital Management held 171 positions worth $1.67B, down 23% from $2.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invenomic Capital Management withdrew a net $533M in Q2 2026, closing 55 positions and reducing 68 holdings. Its most notable exit was Chord Energy, an estimated $73.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Invenomic Capital Management opened a new position in Charter Communications worth $40.2M.
- Invenomic Capital Management's largest Q2 2026 buy was Charter Communications: 282,416 shares worth $40.2M.
- Invenomic Capital Management added most to Universal Health Services in Q2 2026, an estimated $39.4M increase.
- Invenomic Capital Management's biggest Q2 2026 reduction was Haemonetics, cutting an estimated $28.8M.
- Invenomic Capital Management fully exited Chord Energy in Q2 2026, selling an estimated $73.2M.
- Invenomic Capital Management's ten largest holdings make up 29% of its $1.67B portfolio in Q2 2026.
- Invenomic Capital Management opened 21 new positions and closed 55 in Q2 2026.
- Invenomic Capital Management's portfolio value fell 23% quarter-over-quarter to $1.67B.
Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.